ATACAND HCT
Active substance: CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE
TABLET · CANDESARTAN CILEXETIL 32 mg/1, HYDROCHLOROTHIAZIDE 12.5 mg/1
United StatesActive
Marketing holder: ANI Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- CANDESARTAN CILEXETIL · 32 mg/1
- HYDROCHLOROTHIAZIDE · 12.5 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-5065-716d-9fe6-4682b84a1d5b,01a1208c-6230-73b6-adcc-798d36f00a7d,01a1208c-6250-7843-a480-6aed671ebddb,01a1208c-8a94-7862-b868-fe5ce3ab4f02,01a1208c-b32b-7f0e-a513-753799b7abe7;count=40 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 62559-651
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 62559-651 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 62559-651 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 62559-651 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 62559-651 · Verified 2026-10-09 · open in source